L&C BIO Co.,LTD (290650.KQ) — Stock Score Summary

L&C BIO Co.,LTD (290650.KQ) has a MoatMap StockRank of 13/100 based on Quality (34/100), Value (21/100), and Momentum (42/100) factor scores. The current signal is STRONG SELL.

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Key Financial Metrics

Price$54.50
Market Cap$1.3B
P/E (Forward)37.52
Price/Book10.16
Return on Equity-53.4%
Return on Invested Capital-70.4%
Debt/Equity41.03
Gross Margin55.0%
Operating Margin19.8%
Revenue Growth71.4%
Dividend Yield0.1%
Free Cash Flow$45K

L&C BIO Co.,LTD operates in the Medical Devices industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is L&C BIO Co.,LTD’s (290650.KQ) StockRank?
MoatMap’s StockRank for L&C BIO Co.,LTD (290650.KQ) is 13/100, with a Strong Sell signal. It is a composite of Quality (34), Value (21), and Momentum (42) factor ranks across MoatMap’s 19,000+ stock universe.
Does L&C BIO Co.,LTD have an economic moat?
L&C BIO Co.,LTD (290650.KQ) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is L&C BIO Co.,LTD a buy, hold, or sell?
MoatMap’s current signal for L&C BIO Co.,LTD (290650.KQ) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is L&C BIO Co.,LTD in?
L&C BIO Co.,LTD (290650.KQ) operates in the Healthcare sector, specifically the Medical Devices industry (South Korea).